Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 39 of 39 entries
View as:
Clinical-pathological Characterization and Outcomes of Metastatic Urothelial Cancer in Latin America
Phase: N/A
Priority: Normal
Start: 08/01/19
End: 02/28/22
Due: 02/28/23
Phase: N/A
Priority: Normal
Start: 06/09/23
End: 04/24/25
Due: 04/24/26
Phase: N/A
Priority: Normal
Start: 03/05/21
End: 12/20/24
Due: 12/20/25
Phase: N/A
Priority: Normal
Start: 01/14/20
End: 05/07/25
Due: 05/07/26
Phase: N/A
Priority: Normal
Start: 08/11/23
End: 09/24/24
Due: 09/24/25
Phase: N/A
Priority: Normal
Start: 09/01/22
End: 07/11/24
Due: 07/11/25
Phase: N/A
Priority: Normal
Start: 07/21/23
End: 05/31/25
Due: 05/31/26
Phase: N/A
Priority: Normal
Start: 03/01/21
End: 03/01/21
Due: 03/01/22
Phase: N/A
Priority: Normal
Start: 05/24/23
End: 07/31/27
Due: 07/31/28
Phase: N/A
Priority: Normal
Start: 07/25/18
End: 08/04/23
Due: 08/04/24
Phase: N/A
Priority: Normal
Start: 04/30/25
End: 02/28/28
Due: 02/28/29
Phase: N/A
Priority: Normal
Start: 08/31/14
End: 12/31/16
Due: 12/31/17
Phase: N/A
Priority: Normal
Start: 01/01/16
End: 04/01/21
Due: 04/01/22
Phase: N/A
Priority: Normal
Start: 12/17/21
End: 08/03/23
Due: 08/03/24